# EDGAR Filing Document

**Accession Number:** 0001711754
**File Stem:** 0001213900-26-069611
**Filing Date:** 2026-6
**Character Count:** 73283
**Document Hash:** 9ee2a72c45c9d9690ee2c27a969565b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-069611.hdr.sgml**: 20260617

**ACCESSION NUMBER**: 0001213900-26-069611

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260616

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260617

**DATE AS OF CHANGE**: 20260617

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Inmune Bio, Inc.
- **CENTRAL INDEX KEY:** 0001711754
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 475205835
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38793
- **FILM NUMBER:** 261098221

**BUSINESS ADDRESS:**
- **STREET 1:** 225 NE MIZNER BLVD, SUITE 640
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33432
- **BUSINESS PHONE:** 8589643720

**MAIL ADDRESS:**
- **STREET 1:** 225 NE MIZNER BLVD, SUITE 640
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33432

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): June 16, 2026

---

| |
|:---|
| **INMUNE BIO INC.** |
| (Exact name of registrant as specified in charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-38793** | **47-5205835** |
| (State or other jurisdiction | (Commission File Number) | (IRS Employer |
| of incorporation) |  | Identification No.) |

---

**<u>225 NE Mizner Blvd., Suite 640 Boca Raton, Florida 33432</u>**

(Address of Principal Executive Offices) (Zip Code)

**<u>(561) 710-0512</u>**

(Registrant's Telephone Number, Including Area Code)

**<u>Not Applicable</u>**

(Former Name or Former Address, If Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange on which registered** |
| Common Stock, par value $0.001 per shares INMB | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

As noted in Item 5.07 below, on June 16, 2026, INmune Bio Inc. (the "Company"), held its annual meeting of stockholders (the "Annual Meeting"), where the stockholders of the Company approved the Company's Third Amended and Restated 2021 Stock Incentive Plan (the "Amended Plan"), pursuant to which the shares of the Company's common stock issuable under the Company's Amended and Restated 2021 Stock Incentive Plan was increased from 6,500,000 shares to 9,158,525 shares. In addition, the stockholders approved to implement an evergreen provision for the purpose of increasing the number of shares of common stock reserved for the grant of Awards under the Amended Plan automatically on the first trading day of each calendar year beginning with calendar year 2027 through and including the first trading day of calendar year 2031 by the lesser of: (A) 10.0% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding calendar year or (B) such smaller number of shares as is determined by the Company's board of directors. The Amended Plan was previously approved by the Company's board of directors and as noted below was approved by the Company's stockholders at the Annual Meeting.

For a description of the material terms of the Amended Plan, see Proposal No. 3 in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 23, 2026 (the "Proxy Statement"), which description is incorporated herein by reference. The descriptions of the Amended Plan contained herein and in the Proxy Statement, are qualified in their entirety by reference to the full text of the Amended Plan, a copy of which is filed hereto as Exhibit 10.1.

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

At the Annual Meeting, each share of the Company's common stock was entitled to one vote per share. As of April 20, 2026, the record date for the Annual Meeting, 26,585,258 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.

 ****

***Proposal One: Election of Directors.***

 

Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified.

---

| | | | |
|:---|:---|:---|:---|
| **Nominee** | **Votes For** | **Votes<br> Withheld** | **Broker<br> Non-Votes** |
| David Moss | 6834995 | 2120682 | 8501317 |
| J. Kelly Ganjei | 5955609 | 3000068 | 8501317 |
| Tim Schroeder | 6622916 | 2332761 | 8501317 |
| Scott Juda, JD | 7508310 | 1447367 | 8501317 |
| Marcia Allen | 6342910 | 2612767 | 8501317 |

---

 **

***Proposal Two: Ratification of Appointment of Independent Auditor.***

 **

Stockholders approved the ratification of the appointment of CBIZ CPAs P.C. as the Company's independent auditors for the fiscal year ending December 31, 2026.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 17293255 | 107064 | 56675 | 0 |

---

***Proposal Three: Approval of the Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.***

As noted above, the stockholders approved the Amended Plan.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstentions** | **Broker Non-Votes** |
| 6085086 | 2775224 | 95367 | 8501317 |

---

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1 | [Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.](ea029512901ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **INMUNE BIO INC.** | **INMUNE BIO INC.** |
| Date: June 17, 2026 | By: | */s/ David Moss* |
|  |  | David Moss |
|  |  | Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**THIRD AMENDED AND RESTATED INMUNE BIO INC.<br> 2021 STOCK INCENTIVE PLAN**

**1 General**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 **Purpose**. The purposes of the Third Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan (the "Plan") is to promote the interests of INmune Bio Inc. (the "Company") and the stockholders of the Company by providing (i) executive officers and other employees of the Company and its Subsidiaries (as defined below), (ii) certain advisors who perform services for the Company and its Subsidiaries and (iii) non-employee members of the Board of Directors of the Company (the "Board") with appropriate incentives and rewards to encourage them to enter into and continue in the employ and service of the Company and to acquire a proprietary interest in the long-term success of the Company, as well as to reward the performance of these individuals in fulfilling their personal responsibilities for long-range and annual achievements. The Plan is intended to be a written compensatory plan within the meaning of Rule 701 promulgated under the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 **Effective Date and Term**. The Plan will become effective upon the date it is approved by the stockholders of the Company (the "Effective Date"). Unless terminated earlier by the Committee, the Plan will expire on the tenth (10<sup>th</sup>) anniversary of the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3 **Definitions**. Capitalized terms in the Plan, unless defined elsewhere in the Plan, shall be defined as set forth below:

**162(m) Term.** The term "162(m) Term" means the period starting on the date when the Company's stockholders first approve this Plan and ending on the date of the first meeting of the Company's stockholders that occurs in the fifth year following the year in which the Company's stockholders first approve this Plan.

**Exchange Act.** The term "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder and any successor thereto.

**Affiliated Company.** The term "Affiliated Company" means any company, partnership, association, organization or other entity controlled by, controlling or under common control with the Company.

**Award.** The term "Award" means any award or benefit granted under the Plan, including, without limitation, Options, SARs, Restricted Stock, Restricted Stock Units, Other Stock-Based Awards and Cash-Based Awards.

**Award Agreement.** The term "Award Agreement" means a written Award grant agreement under the Plan.

**Cash-Based Award.** The term "Cash-Based Award" means a right or other interest granted to an Eligible Grantee under Section 4.2(vi) of the Plan that may be denominated or payable in cash, other than an Award pursuant to which the amount of cash is determined by reference to the value of a specific number of shares of Stock. For the avoidance of doubt, dividend equivalents constitute Cash-Based Awards.

**Change of Control.** The term "Change of Control" shall be deemed to occur if and when:

&nbsp;&nbsp;&nbsp;&nbsp;(i) any person, including a "person" as such term is
used in Section 14(d)(2) of the Exchange Act (a "Person"), is or becomes a beneficial owner (as such term
is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50%
or more of the combined voting power of the Company's then outstanding securities;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) individuals who, as of the Effective Date, constitute the Board
(the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any
individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company's stockholders,
was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such
individual were a member of the Incumbent Board, but excluding for this purpose any such individual whose initial assumption of office
occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A
promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person
other than the Board;

&nbsp;&nbsp;&nbsp;&nbsp;(iii) all or substantially all of the assets of the Company are sold,
transferred or distributed, or the Company is dissolved or liquidated; or

&nbsp;&nbsp;&nbsp;&nbsp;(iv) a reorganization, merger, consolidation or other corporate transaction
involving the Company (a "Transaction") is consummated, in each case, with respect to which the stockholders of the Company
immediately prior to such Transaction do not, immediately after the Transaction, own more than 50% of the combined voting power of the
Company or other corporation resulting from such Transaction in substantially the same respective proportions as such stockholders'
ownership of the voting power of the Company immediately before such Transaction.

Notwithstanding the foregoing or any other provision of this Plan, the term Change of Control shall include a sale of assets, merger or other transaction effected, except for the purpose of changing the domicile of the Company.

**Code.** The term "Code" means the Internal Revenue Code of 1986, as amended. A reference to any provision of the Code shall include reference to any successor provision of the Code.

**Committee.** The term "Committee" means the committee of the Board described in Section 2 hereof and any sub-committee established by such Committee pursuant to Section 2.4.

**Covered Employee.** The term "Covered Employee" means an Employee who is, or who is anticipated to become, between the time of grant and payment of the Award, a "covered employee," as such term is defined in Section 162(m)(3) of the Code (or any successor section thereof).

**Disability.** The term "Disability" means "Disability" as defined in any Award Agreement to which the Grantee is a party.

**Eligible Grantee.** The term "Eligible Grantee" shall mean any Employee, Non-Employee Director or Key Advisor, as determined by the Committee in its sole discretion.

**Employee.** The term "Employee" means an active employee of the Company or a Subsidiary, but excluding any person who is classified by the Company or a Subsidiary as a "contractor" or "consultant," no matter how characterized by the Internal Revenue Service, other governmental agency or a court, or any employee who is not actively employed, as determined by the Committee. Any change of characterization of an individual by the Internal Revenue Service or any court or government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the Committee determines otherwise.

**Fair Market Value.** For purposes of determining the "Fair Market Value" of a share of Stock as of any date, the "Fair Market Value" as of that date shall be, unless otherwise determined by the Committee, the closing sale price during regular trading hours of the Stock on the immediately preceding date on the principal securities market in which shares of Stock is then traded; or, if there were no trades on that date, the closing sale price during regular trading hours of the Stock on the first trading day prior to that date. If the Stock is not publicly traded at the time a determination of Fair Market Value is required to be made hereunder, the determination of such amount shall be made by the Committee in such manner as it deems appropriate.

**Grantee.** The term "Grantee" means an Employee, Non-Employee Director or Key Advisor of the Company or a Subsidiary who has been granted an Award under the Plan.

**ISO.** The term "ISO" means any Option intended to be and designated as an incentive stock option within the meaning of Section 422 of the Code.

**Key Advisor.** The term "Key Advisor" means a consultant or other key advisor who performs services for the Company or a Subsidiary.

**Non-Employee Director.** The term "Non-Employee Director" means a member of the Board who is not an Employee.

**NQSO.** The term "NQSO" means any Option that is not designated as an ISO, or which is designated by the Committee as an ISO but which subsequently fails or ceases to qualify as an ISO.

**Option.** The term "Option" means a right, granted to an Eligible Grantee under Section 4.2(i), to purchase shares of Stock. An Option may be either an ISO or an NQSO.

**Other Stock-Based Award.** The term "Other Stock-Based Award" means a right or other interest granted to an Eligible Grantee under Section 4.2(v) of the Plan that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Stock, including but not limited to (i) unrestricted Stock awarded as a bonus or upon the attainment of Performance Goals or otherwise as permitted under the Plan, and (ii) a right granted to an Eligible Grantee to acquire Stock from the Company containing terms and conditions prescribed by the Committee.

**Performance Goals.** The term "Performance Goals" means performance goals based on the attainment by the Company or any Subsidiary of the Company or any Affiliated Company (or any division or business unit of any such entity), or any two or more of the foregoing, of performance goals pre-established by the Committee in its sole discretion, based on one or more of the following criteria (if applicable, such criteria shall be determined in accordance with generally accepted accounting principles ("GAAP") or based upon the Company's GAAP financial statements): (i) the attainment of certain target levels of, or a specified percentage increase in, revenues, earnings, income before taxes and extraordinary items, net income, operating income, earnings before income tax, earnings before interest, taxes, depreciation and amortization or a combination of any or all of the foregoing; (ii) the attainment of certain target levels of, or a percentage increase in, after-tax or pre-tax profits including, without limitation, that attributable to continuing and/or other operations; (iii) the attainment of certain target levels of, or a specified increase in, operational cash flow; (iv) the achievement of a certain level of, reduction of, or other specified objectives with regard to limiting the level of increase in, all or a portion of, the Company's bank debt or other long-term or short-term public or private debt or other similar financial obligations of the Company, which may be calculated net of such cash balances and/or other offsets and adjustments as may be established by the Committee; (v) earnings per share or the attainment of a specified percentage increase in earnings per share or earnings per share from continuing operations; (vi) the attainment of certain target levels of, or a specified increase in return on capital employed or return on invested capital; (vii) the attainment of certain target levels of, or a percentage increase in, after-tax or pre-tax return on stockholders' equity; (viii) the attainment of certain target levels of, or a specified increase in, economic value added targets based on a cash flow return on investment formula; (ix) the attainment of certain target levels in, or specified increases in, the fair market value of the shares of the Company's common stock; (x) the growth in the value of an investment in the Company's common stock; (xi) the attainment of a certain level of, reduction of, or other specified objectives with regard to limiting the level in or increase in, all or a portion of controllable expenses or costs or other expenses or costs; (xii) gross or net sales, revenue and growth of sales revenue (either before or after cost of goods, selling and general administrative expenses, research and development expenses and any other expenses or interest); (xiii) total stockholder return; (xiv) return on assets or net assets; (xv) return on sales; (xvi) operating profit or net operating profit; (xvii) operating margin; (xviii) gross or net profit margin; (xix) cost reductions or savings; (xx) productivity; (xxi) operating efficiency; (xxii) working capital; or (xxiii) market share; (xxiv) customer satisfaction; (xxv) workforce diversity; (xxvi) results of clinical trials; (xxvii) acceptance of a new drug application by a regulatory body; (xxviii) regulatory body approval for commercialization of a product; (xxix) launch of a new drug; (xxx) completion of out-licensing, in-licensing or disposition of product candidates or other acquisition or disposition projects; and (xxxi) to the extent that an Award is not intended to comply with Section 162(m) of the Code, other measures of performance selected by the Board. Subject to the limitations in Section 4.2, the Committee in its sole discretion may designate additional business criteria on which the Performance Goals may be based or adjust, or modify or amend the aforementioned business criteria. The relative weights of the criteria that comprise the Performance Goals shall be determined by the Committee in its sole discretion. In establishing the Performance Goals for a performance period, the Committee may establish different Performance Goals for individual Grantees or groups of Grantees. Subject to the limitations in Section 4.2(ix)(d), the Committee in its sole discretion shall have the authority to make equitable adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or any Subsidiary of the Company or any Affiliated Company or the financial statements of the Company or any Subsidiary of the Company or any Affiliated Company, in response to changes in applicable laws or regulations, including changes in generally accepted accounting principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business, as applicable. Performance Goals may include a threshold level of performance below which no Award will be earned, a level of performance at which the target amount of an Award will be earned and a level of performance at which the maximum amount of the Award will be earned.

**Restricted Stock.** The term "Restricted Stock" means an Award of shares of Stock to an Eligible Grantee under Section 4.2(iii) that may be subject to certain restrictions and to a risk of forfeiture. Stock issued upon the exercise of Options or SARs is not "Restricted Stock" for purposes of the plan, even if subject to post-issuance transfer restrictions or forfeiture conditions. When Restricted Stock vests, it ceases to be "Restricted Stock" for purposes of the Plan.

**Restricted Stock Unit.** The term "Restricted Stock Unit" means a right granted to an Eligible Grantee under Section 4.2(iv) to receive Stock or cash at the end of a specified deferral period, which right may be conditioned on the satisfaction of specified performance or other criteria.

**Retirement.** The term "Retirement" means any termination of employment or service as an Employee, Non-Employee Director or Key Advisor as a result of retirement in good standing under the rules of the Company or a Subsidiary, as applicable, then in effect.

**Rule 16b-3.** The term "Rule 16b-3" means Rule 16b-3, as from time to time in effect promulgated by the Securities and Exchange Commission under Section 16 of the Exchange Act, including any successor to such Rule.

**Securities Act.** The term "Securities Act" means the Securities Act of 1933, as amended.

**Stock.** The term "Stock" means shares of the common stock, par value $0.001 per share, of the Company.

**Stock Appreciation Right or SAR.** The term "Stock Appreciation Right" or "SAR" means the right, granted to an Eligible Grantee under Section 4.2(ii), to be paid an amount measured by the appreciation in the Fair Market Value of Stock from the date of grant to the date of exercise of the right.

**Subsidiary.** The term "Subsidiary" means any present or future subsidiary corporation of the Company within the meaning of Section 424(f) of the Code, and any present or future business venture designated by the Committee in which the Company has a significant interest, including, without limitation, any subsidiary corporation in which the Company has at least a 50% ownership interest, as determined in the discretion of the Committee.

**2 Administration**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 **Committee**. The authority to manage the operation of and administer the Plan shall be vested in a committee (the "Committee") in accordance with this Section 2. The Committee shall be selected by the Board, and shall consist solely of two or more members of the Board who are non-employee directors within the meaning of Rule 16b-3 and are outside directors within the meaning of Code Section 162(m). Unless otherwise determined by the Board, the Company's Compensation Committee shall be designated as the "Committee" hereunder. If the Board, at any time, consists of only one member, such sole member may take all actions granted to the Committee hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 **Powers of the Committee**. The Committee's administration of the Plan shall be subject to the following:

&nbsp;&nbsp;&nbsp;&nbsp;(i) Subject to the provisions of the Plan, the Committee will have
the authority and discretion to select from among the Eligible Grantees those persons who shall receive Awards, to determine the time
or times of receipt, to determine the types of Awards and the number of shares covered by the Awards, and to establish the terms, conditions,
performance criteria, restrictions, and other provisions of such Awards;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) The Committee will have the authority and discretion to interpret
the Plan, to establish, amend, and rescind any rules and regulations relating to the Plan, to determine the terms and provisions of any
Award Agreement made pursuant to the Plan, and to make all other determinations that may be necessary or advisable for the administration
of the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;(iii) Any interpretation of the Plan by the Committee and any decision
made by it under the Plan is final and binding on all persons; and

&nbsp;&nbsp;&nbsp;&nbsp;(iv) In managing the operation of and administering the Plan, the
Committee shall take action in a manner that conforms to the articles of incorporation and by-laws of the Company, and applicable
state corporate law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 **Prohibition Against Repricing**. Notwithstanding any provision of the Plan to the contrary, in no event shall any action be taken under the Plan that constitutes a Repricing of any Option or SAR granted under the Plan, or of any option or stock appreciation right granted under the any other plan of the Company or of an acquired company, except with approval of the stockholders of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 **Delegation of Authority**. To the extent not inconsistent with applicable law, the rules of the NASDAQ Stock Market or other provisions of the Plan, the Committee may, at any time, allocate all or any portion of its responsibilities and powers to any one or more of its members or, with respect to Awards made to Employees other than executive officers, the Chief Executive Officer, including without limitation, the power to designate Grantees hereunder and determine the amount, timing and terms of Awards hereunder. Any such allocation or delegation may be revoked by the Committee at any time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 **Indemnification**. Each person who is or shall have been a member of the Committee, or the Board, shall be indemnified and held harmless by the Company against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken in good faith or failure to act in good faith under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company's approval, or paid by him or her in satisfaction of any judgment in any such action, suit or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall be in addition to any other rights of indemnification or elimination of liability to which such persons may be entitled under the Company's articles of incorporation or by-laws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.

**3 Available Shares of Stock Under the Plan**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 **Shares Available for Awards**. Subject to the adjustments described below, the maximum number of shares of Stock reserved for the grant of Awards under the Plan shall be 9,158,525 . The number of shares of Stock reserved for the grant of Awards under the Plan shall increase automatically on the first trading day of each calendar year beginning with calendar year 2027 through and including the first trading day of calendar year 2031 by the lesser of: (A) 10.0% of the total number of shares of Stock outstanding on December 31 of the immediately preceding calendar year or (B) such smaller number of shares as is determined by the Board. Of the maximum number of shares of Stock reserved for the grant of Awards under the Plan, no more than 1,000,000 of such shares may be issued pursuant to stock-settled Awards other than Options (that is, Restricted Stock, Restricted Stock Units, SARs, Performance Awards, Other Stock-Based Awards and dividend equivalent Awards, in each case to the extent settled in shares of Common Stock).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 **Forfeited, Cancelled and Expired Awards**. Awards granted under the Plan that are forfeited, expire or are canceled or settled without issuance of Stock shall not count against the maximum number of shares that may be issued under the Plan as set forth in Section 3.1 and shall be available for future Awards under the Plan. Notwithstanding the foregoing, any and all Stock that is (i) withheld or tendered in payment of an Option exercise price; (ii) withheld by the Company to satisfy any tax withholding obligation; (iii) covered by a SAR (to the extent that it is settled in Stock, without regard to the number of shares of Stock that are actually issued to the Grantee upon exercise); (iv) withheld by the Company to satisfy any debt or other obligation owed to the Company or any Subsidiary, and (v) any fractional shares of Common Stock that are cancelled pursuant to the Plan, shall be considered issued pursuant to the Plan and shall not be added to the maximum number of shares of Stock that may be issued under the Plan as set forth in Section 3.1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 **Adjustments**. In the event of any change in the Company's capital structure, including but not limited to a change in the number of shares of Stock outstanding, on account of (i) any stock dividend, stock split, reverse stock split or any similar equity restructuring, or (ii) any combination or exchange of equity securities, merger, consolidation, recapitalization, reorganization, or divesture or any other similar event affecting the Company's capital structure, to reflect such change in the Company's capital structure, the Committee shall make appropriate equitable adjustments to the maximum number of shares of Stock that may be issued under the Plan as set forth in Section 3.1. In the event of any extraordinary dividend, divestiture or other distribution (other than ordinary cash dividends) of assets to stockholders, or any transaction or event described above, to the extent necessary to prevent the enlargement or diminution of the rights of Grantees, the Committee shall make appropriate equitable adjustments to the number or kind of shares subject to an outstanding Award, the exercise price applicable to an outstanding Award, and/or a Performance Goals. Any adjustments under this Section 3.3 shall be consistent with Section 409A or 424 of the Code, to the extent applicable, and made in a manner that does not adversely affect the exemption provided pursuant to Rule 16b-3 or qualification under Section 162(m) of the Code, to the extent each may be applicable. The Company shall give each Grantee notice of an adjustment to an Award hereunder and, upon notice, such adjustment shall be final, binding and conclusive for all purposes. Notwithstanding the foregoing, the Committee shall decline to adjust any Award made to a Participant if such adjustment would violate applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 **Fractional Shares**. The Company shall not be obligated to issue any fractional shares of Stock in settlement of Awards granted under the Plan. Except as otherwise provided in an Award Agreement or determined by the Committee, (i) the total number of shares issuable pursuant to the exercise, vesting or earning of an Award shall be rounded down to the nearest whole share, and (ii) no fractional shares shall be issued. The Committee may, in its discretion, determine that a fractional share shall be settled in cash.

**4 Awards**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 **General**. The term of each Award shall be for such period as may be determined by the Committee, subject to the limitations set forth below. Subject to the terms of the Plan and any applicable Award Agreement, payments to be made by the Company or any Subsidiary of the Company upon the grant, maturation, or exercise of an Award may be made in such forms as the Committee shall determine at the date of grant or thereafter, including, without limitation, cash, Stock, or other property. In addition to the foregoing, the Committee may impose on any Award or the exercise thereof, at the date of grant, such additional terms and conditions not inconsistent with the provisions of the Plan, including, but not limited to forfeiture and clawback provisions, as the Committee shall determine; provided, however, that any such terms and conditions shall not be inconsistent with Section 409A of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 **Types of Awards**. The Committee is authorized to grant the Awards described in this Section 4.2, under such terms and conditions as deemed by the Committee to be consistent with the purposes of the Plan. Such Awards may be granted with value and payment contingent upon Performance Goals. Each Award shall be evidenced by an Award Agreement containing such terms and conditions applicable to such Award as the Committee shall determine.

&nbsp;&nbsp;&nbsp;&nbsp;(i) *Options*. The
Committee is authorized to grant Options to Grantees on the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <u>Type of Award</u>. The Award Agreement evidencing an Option
shall designate the Option as either an ISO or an NQSO, as determined in the discretion of the Committee. At the time of the grant of
Options, the Committee may place restrictions on the exercisability or vesting of Options that shall lapse, in whole or in part, upon
the attainment of Performance Goals; provided that such Performance Goals shall relate to periods of performance of at least one fiscal
year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <u>Exercise Price</u>. The exercise price of each Option granted
under this Section 4.2 shall be established by the Committee or shall be determined by a method established by the Committee at
the time the Option is granted; provided, however, that the exercise price shall not be less than 100% of the Fair Market Value of a
share of Stock on the date of grant of the Award. No dividends or dividend equivalents will be paid on shares of Stock subject to an
Option.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. <u>Exercise</u>. Upon satisfaction of the applicable conditions
relating to vesting and exercisability, as determined by the Committee and set forth in the Award Agreement, and upon provision for the
payment in full of the exercise price and applicable taxes due, the Grantee shall be entitled to exercise the Option and receive the
number of shares of Stock issuable in connection with the Option exercise provided, however, that no Option may be exercised more than
ten years after its grant date. Except as set forth in Section 4.3, no NQSO granted hereunder may be exercised after the earlier
of (A) the expiration of the NQSO or (B) unless otherwise provided by the Committee in an Award Agreement, ninety days
after the severance of an NQSO holder's employment or service with the Company or any Subsidiary. The shares issued in connection
with the Option exercise may be subject to such conditions and restrictions as the Committee may determine, from time to time. An Option
may be exercised by any method as may be permitted by the Committee from time to time, including but not limited to any "net exercise"
or other "cashless" exercise method.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. <u>Restrictions Relating to ISOs</u>. In addition to being subject
to the terms and conditions of this Section 4.2(i), ISOs shall comply with all other requirements under Section 422 of the
Code. Accordingly, ISOs may be granted only to Eligible Grantees who are employees (as described in Treasury Regulation Section 1.421-7(h))
of the Company or of any "Parent Corporation" (as defined in Code Section 424(e)) or of any "Subsidiary Corporation"
(as defined in Code Section 424(f)) on the date of grant. The aggregate Fair Market Value (determined as of the time the ISO is
granted) of the Stock with respect to which ISOs (under all option plans of the Company and of any Parent Corporation and of any Subsidiary
Corporation) are exercisable for the first time by an Eligible Grantee during any calendar year shall not exceed $100,000. ISOs shall
not be transferable by the Eligible Grantee otherwise than by will or the laws of descent and distribution and shall be exercisable,
during the Eligible Grantee's lifetime, only by such Eligible Grantee. The Committee shall not grant ISOs to any Employee who,
at the time the ISO is granted, owns stock possessing (after the application of the attribution rules of Section 424(d) of
the Code) more than ten percent (10%) of the total combined voting stock of the Company or of any Parent Corporation or of any Subsidiary
Corporation, unless the exercise price of the ISO is fixed at not less than one hundred and ten percent (110%) of the Fair Market Value
of a share of Common Stock on the date of grant and the exercise of such ISO is prohibited by its terms after the fifth (5 <sup>th</sup>)
anniversary of the ISO's date of grant. In addition, no ISO shall be issued to an Eligible Grantee in tandem with a NQSO issued
to such Eligible Grantee in accordance with Treasury Regulation Section 14a.422A-1, Q/A-39.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) *SARs*. The Committee
is authorized to grant SARs to Grantees on the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <u>In General</u>. SARs may be granted independently or in tandem
with an Option at the time of grant of the related Option. An SAR granted in tandem with an Option shall be exercisable only to the extent
the underlying Option is exercisable. Payment of an SAR may be made in cash, Stock, or a combination of the foregoing, as specified in
the Award Agreement or determined in the sole discretion of the Committee. At the time of the grant of SARs, the Committee may place
restrictions on the exercisability or vesting of SARs that shall lapse, in whole or in part, upon the attainment of Performance Goals;
provided that such Performance Goals shall relate to periods of performance of at least one fiscal year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <u>Term and Exercisability of SARs</u>. SARs shall be exercisable
over the exercise period at such times and upon such conditions as the Committee may determine, as reflected in the Award Agreement;
provided, however, that no SAR may be exercised more than ten years after its grant date. Except as set forth in Section 4.3,
no SAR granted hereunder may be exercised after the earlier of (A) the expiration of the SAR or (B) unless otherwise provided
by the Committee in an Award Agreement, ninety days after the severance of an SAR holder's employment or service with the
Company or any Subsidiary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. <u>Payment</u>. An SAR shall confer on the Grantee a right to
receive an amount with respect to each share of Stock subject thereto, upon exercise thereof, equal to the excess of (A) the Fair
Market Value of one share of Stock on the date of exercise over (B) the grant price of the SAR (which in the case of an SAR granted
in tandem with an Option shall be equal to the exercise price of the underlying Option, and which in the case of any other SAR shall
be such price as the Committee may determine but in no event shall be less than the Fair Market Value of a share of Stock on the date
of grant of such SAR). An SAR may be exercised by giving written notice of such exercise to the Committee or its designated agent. No
dividends or dividend equivalents will be paid on shares of Stock subject to an SAR.

&nbsp;&nbsp;&nbsp;&nbsp;(iii) *Restricted Stock*.
The Committee is authorized to grant Restricted Stock to Grantees on the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <u>Issuance and Restrictions</u>. Restricted Stock shall be
subject to such restrictions on transferability and other restrictions, if any, as the Committee may impose at the date of grant, which
restrictions may lapse separately or in combination at such times, under such circumstances, in such installments, or otherwise, as the
Committee may determine. The Committee may place restrictions on Restricted Stock that shall lapse, in whole or in part, upon the attainment
of Performance Goals; provided that such Performance Goals shall relate to periods of performance of at least one fiscal year. Except
to the extent restricted under the Award Agreement relating to the Restricted Stock, a Grantee granted Restricted Stock shall have all
of the rights of a stockholder including, without limitation, the right to vote Restricted Stock and the right to receive dividends thereon.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <u>Certificates for Stock</u>. Restricted Stock granted under
the Plan may be evidenced in such manner as the Committee shall determine. If certificates representing Restricted Stock are registered
in the name of the Grantee, such certificates shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable
to such Restricted Stock, and the Company may retain physical possession of the certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. <u>Dividends</u>. Except to the extent restricted under the
applicable Award Agreement, cash dividends paid on Restricted Stock shall be paid at the dividend payment date subject to no restriction.
Unless otherwise determined by the Committee, Stock distributed in connection with a stock split or stock dividend shall be subject to
the transfer restrictions, forfeiture risks and vesting conditions to the same extent as the Restricted Stock with respect to which such
Stock or other property has been distributed. Notwithstanding the foregoing, the Committee may not provide for the current payment of
dividends for Restricted Stock subject to Performance Goals; for such Awards, dividends may accrue but shall not be payable unless and
until the Award vests upon satisfaction of the applicable Performance Goals and all other applicable conditions to vesting.

&nbsp;&nbsp;&nbsp;&nbsp;(iv) *Restricted Stock Units*.
The Committee is authorized to grant Restricted Stock Units to Grantees, subject to the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <u>Conditions to Vesting</u>. At the time of the grant of Restricted
Stock Units, the Committee may place restrictions on Restricted Stock Units that shall lapse, in whole or in part, upon the attainment
of Performance Goals; provided that such Performance Goals shall relate to periods of performance of at least one fiscal year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. <u>Benefit Upon Vesting</u>. Unless otherwise provided in an
Award Agreement, upon the vesting of a Restricted Stock Unit, there shall be delivered to the Grantee, within 30 days of the date
on which such Award (or any portion thereof) vests, the number of shares of Stock equal to the number of Restricted Stock Units becoming
so vested.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. <u>Dividend Equivalents</u>. To the extent provided in an Award
Agreement, subject to the requirements of Section 409A of the Code, an Award of Restricted Stock Units may provide the Grantee
with the right to receive dividend equivalent payments with respect to Stock subject to the Award (both before and after the Stock subject
to the Award is earned, vested, or acquired), which payments may be either made currently or credited to an account for the Grantee,
and may be settled in cash or Stock, as determined by the Committee. Any such settlements and any such crediting of dividend equivalents
may, at the time of grant of the Restricted Stock Unit, be made subject to the transfer restrictions, forfeiture risks, vesting and conditions
of the Restricted Stock Units and subject to such other conditions, restrictions and contingencies as the Committee shall establish
at the time of grant of the Restricted Stock Unit, including the reinvestment of such credited amounts in Stock equivalents, provided
that all such conditions, restrictions and contingencies shall comply with the requirements of Section 409A of the Code. Notwithstanding
the foregoing in this Section 4.2(iv)(c), dividend equivalents may accrue on unearned Restricted Stock Units subject to Performance
Goals but shall not be payable unless and until the applicable Performance Goals are met and certified.

&nbsp;&nbsp;&nbsp;&nbsp;(v) *Other Stock-Based Awards*.
The Committee is authorized to grant Awards to Grantees in the form of Other Stock-Based Awards, as deemed by the Committee to be
consistent with the purposes of the Plan. At the time of the grant of Other Stock-Based Awards, the Committee may place restrictions
on the payout or vesting of Other Stock-Based Awards that shall lapse, in whole or in part, upon the attainment of Performance Goals;
provided that such Performance Goals shall relate to periods of performance of at least one fiscal year. The Committee shall determine
the terms and conditions of such Awards at the date of grant. Other Stock-Based Awards may not be granted with the right to receive
dividend equivalent payments.

&nbsp;&nbsp;&nbsp;&nbsp;(vi) *Cash-Based Awards*.
The Committee is authorized to grant Awards to Grantees in the form of Cash-Based Awards, as deemed by the Committee to be consistent
with the purposes of the Plan. At the time of the grant of Cash-Based Awards, the Committee may place restrictions on the payout
or vesting of Cash-Based Awards that shall lapse, in whole or in part, upon the attainment of Performance Goals. The Committee shall
determine the terms and conditions of such Awards at the date of grant.

&nbsp;&nbsp;&nbsp;&nbsp;(vii) *Settlement of Options and SARs*. Shares of Stock delivered pursuant to the exercise of an Option or SAR shall be subject to such conditions, restrictions
and contingencies as the Committee may establish in the applicable Award Agreement. Settlement of SARs may be made in shares of Stock
(valued at their Fair Market Value at the time of exercise), in cash, or in a combination thereof, as determined in the discretion of
the Committee and set forth in the Award Agreement. The Committee, in its discretion, may impose such conditions, restrictions and contingencies
with respect to shares of Stock acquired pursuant to the exercise of an Option or an SAR as the Committee determines to be desirable.

&nbsp;&nbsp;&nbsp;&nbsp;(viii) *Vesting; Additional Terms*.
Except as set forth in Section 4.3, other than Options, SARs, Restricted Stock, Restricted Stock Units or Other Stock-Based Awards
conditioned upon the attainment of Performance Goals that relate to performance periods of at least one fiscal year, Options, SARs, Restricted
Stock, Restricted Stock Units or Other Stock-Based Awards granted hereunder shall vest as determined by the Committee and set
forth in the Award Agreement. The term of any Award granted under the Plan will not exceed ten years from the date of grant.

&nbsp;&nbsp;&nbsp;&nbsp;(ix) *Qualified Performance-Based Compensation*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The Committee may determine that Restricted Stock, Restricted
Stock Units, Other Stock-Based Awards or Cash-Based Awards granted to a Covered Employee shall be considered "qualified
performance-based compensation" under section 162(m) of the Code, in which case the provisions of this Section 4.2(ix) shall
apply. As required pursuant to Section 162(m) of the Code and the regulations promulgated thereunder, the Committee's
authority to grant new awards that are intended to qualify as performance-based compensation within the meaning of Section 162(m) of
the Code (other than qualifying Options and qualifying SARs) shall terminate upon the first meeting of the Company's stockholders
that occurs in the fifth year following the year in which the Company's stockholders first approve this Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. When Awards are made under this Section 4.2(ix), the Committee
shall establish in writing (i) the objective Performance Goals that must be met, (ii) the period during which performance will
be measured, (iii) the maximum amounts that may be paid if the Performance Goals are met, and (iv) any other conditions that
the Committee deems appropriate and consistent with the requirements of Section 162(m) of the Code for "qualified performance-based compensation."
The Performance Goals shall satisfy the requirements for "qualified performance-based compensation," including the requirement
that the achievement of the goals be substantially uncertain at the time they are established and that the Performance Goals be established
in such a way that a third party with knowledge of the relevant facts could determine whether and to what extent the Performance Goals
have been met. The Committee shall not have discretion to increase the amount of compensation that is payable, but may reduce the amount
of compensation that is payable, pursuant to Awards identified by the Committee as "qualified performance-based compensation."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Performance Goals must be pre-established by the Committee.
A Performance Goal is considered pre-established if it is established in writing not later than 90 days after the commencement
of the period of service to which the Performance Goal relates, provided that the outcome is substantially uncertain at the time the
Committee actually established the goal. However, in no event will a Performance Goal be considered pre-established if it is established
after 25% of the period of service (as scheduled in good faith at the time the goal is established) has elapsed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. The Committee in its sole discretion shall have the authority
to make equitable adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or
any Subsidiary of the Company or any Affiliated Company or the financial statements of the Company or any Subsidiary of the Company or
any Affiliated Company, in response to changes in applicable laws or regulations, including changes in generally accepted accounting
principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent
in occurrence or related to the disposal of a segment of a business, as applicable, provided such adjustment occurs in writing not later
than 90 days after the commencement of the period of service to which the Performance Goal relates (and in no event later than the
date that 25% of the period of service has elapsed). In addition, the Committee may specify that certain equitable adjustments to the
Performance Goals will be made during the applicable Performance Period, provided such specification occurs in writing not later than
90 days after the commencement of the period of service to which the Performance Goal relates (and in no event later than the date
that 25% of the period of service has elapsed).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. The Committee shall certify the performance results for the
performance period specified in the Award Agreement after the performance period ends. The Committee shall determine the amount, if any,
to be paid pursuant to each Award based on the achievement of the Performance Goals and the satisfaction of all other terms of the Award
Agreement. Subject to the provisions of Section 3.3 relating to capitalization adjustments, at such time as the Company may be subject
to the applicable provisions of Section 162(m) of the Code, a maximum of 50,000 shares of Stock subject to qualified performance-based compensation
may be granted to any Eligible Grantee during any calendar year during the 162(m) Term.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. The Committee may provide in the Award Agreement that Awards
under this Section 4.2(ix) shall be payable, in whole or in part, in the event of the Grantee's death or Disability,
or under other circumstances consistent with the Treasury regulations and rulings under Section 162(m) of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 **Change of Control of the Company.**

&nbsp;&nbsp;&nbsp;&nbsp;(i) The Committee may, at the time an Award is made or at any time
prior to, coincident with or after the time of a Change of Control:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. provide for the adjustment of any Performance Goals as the Committee
deems necessary or appropriate to reflect the Change of Control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. provide for the cancellation of any Awards then outstanding
if the surviving entity or acquiring entity (or the surviving or acquiring entity's parent company) in the Change of Control replaces
the Awards with new rights of substantially equivalent value, as determined by the Committee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. provide that upon an involuntary termination of a Participant's
employment as a result of a Change of Control, any time periods shall accelerate, and any other conditions relating to the vesting, exercise,
payment or distribution of an Award shall be waived; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. provide that Awards shall be purchased for an amount of cash
equal to the amount that could have been obtained for the shares covered by a Restricted Stock Award if it had been vested and or by
an Option or SAR if it had been exercised at the time of the Change of Control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Notwithstanding any other provisions of the Plan or an Award Agreement to the contrary, the vesting, payment, purchase or distribution of an Award for any Grantee whose service to the Company has not terminated shall automatically be accelerated by reason of a Change of Control for any Grantee with respect to any outstanding grants. Further, unless otherwise provided by the applicable Award Agreement or determined by the Committee, any portion of an Award outstanding immediately prior to a Change of Control, the exercisability and/or vesting of such portion of the Award held by a Participant whose service to the Company has not terminated prior to Change in Control shall be accelerated in full effective as of a date prior to, but conditioned upon, the consummation of a Change in Control.

**5 Operation**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 **Duration**. Grants may be made under the Plan through June 1, 2031. In the event of Plan termination while Awards remain outstanding, the Plan shall remain in effect as long as any Awards under it are outstanding, although no further grants may be made following Plan termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 **Uncertificated Stock**. Nothing contained in the Plan shall prohibit the issuance of Stock on an uncertificated basis, to the extent allowed by the Company's Articles of Incorporation and Bylaws, by applicable law and by the applicable rules of any stock exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 **Tax Withholding**. All distributions under the Plan are subject to withholding of all applicable taxes, and the Committee may condition the delivery of any shares or other benefits under the Plan on satisfaction of the applicable withholding obligations. The Committee, in its discretion, and subject to such requirements as the Committee may impose prior to the occurrence of such withholding, may permit such withholding obligations to be satisfied through cash payment by the Grantee, through the surrender of shares of Stock which the Grantee already owns, through withholding from other compensation payable to the Grantee or through the surrender of unrestricted shares of Stock to which the Grantee is otherwise entitled under the Plan, but only to the extent of the minimum amount required to be withheld under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 **Use of Shares.** Subject to the limitations on the number of shares of Stock that may be delivered under the Plan, the Committee may use available shares of Stock as the form of payment for compensation, grants or rights earned or due under any other compensation plans or arrangements of the Company or a Subsidiary, including the plans and arrangements of the Company or a Subsidiary assumed in business combinations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 **Nontransferability**. Awards granted under the Plan, and during any period of restriction on transferability, shares of Common Stock issued in connection with the exercise of an Option or a SAR, or vesting of a Restricted Stock Award may not be sold, pledged, hypothecated, assigned, margined or otherwise transferred by a Grantee in any manner other than by will or the laws of descent and distribution, unless and until the shares underlying such Award have been issued, and all restrictions applicable to such shares have lapsed or have been waived by the Committee. No Award or interest or right therein shall be subject to the debts, contracts or engagements of a Grantee or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law, by judgment, lien, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy and divorce), and any attempted disposition thereof shall be null and void, of no effect, and not binding on the Company in any way. Notwithstanding the foregoing, the Committee may permit Options and/or shares issued in connection with an Option or a SAR exercise that are subject to restrictions on transferability, to be transferred one time and without payment or consideration to a member of a Grantee's immediate family or to a trust or similar vehicle for the benefit of a Grantee's immediate family members. During the lifetime of a Grantee, all rights with respect to Awards shall be exercisable only by such Grantee or, if applicable pursuant to the preceding sentence, a permitted transferee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.6 **Form and Time of Elections**. Unless otherwise specified herein, each election required or permitted to be made by any Grantee or other person entitled to benefits under the Plan, and any permitted modification, or revocation thereof, shall be in writing filed with the Committee at such times, in such form, and subject to such restrictions and limitations, not inconsistent with the terms of the Plan, as the Committee shall require.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.7 **Agreement with Company**. An Award under the Plan shall be subject to such terms and conditions, not inconsistent with the Plan, as the Committee shall, in its sole discretion, prescribe. The terms and conditions of any Award to any Grantee shall be reflected in such form of written document as is determined by the Committee. A copy of such document shall be provided to the Grantee, and the Committee may, but need not, require that the Grantee shall sign a copy of such document. Such document is referred to in the Plan as an "Award Agreement" regardless of whether any Grantee signature is required.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.8 **Gender and Number**. Where the context admits, words in any gender shall include any other gender, words in the singular shall include the plural and the plural shall include the singular.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.9 **Limitation of Implied Rights.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The Plan shall at all times be unfunded and neither a Grantee nor any other person shall, by reason of participation in the Plan, acquire any right in or title to any assets, funds or property of the Company or any Subsidiary whatsoever, including, without limitation, any specific funds, assets, or other property which the Company or any Subsidiary, in its sole discretion, may set aside in anticipation of a liability under the Plan. Nothing contained in the Plan and no action taken pursuant hereto shall create or be construed to create a fiduciary relationship between the Company and any Grantee or any other person. A Grantee shall have only a contractual right to the Stock or amounts, if any, payable under the Plan, unsecured by any assets of the Company or any Subsidiary, and nothing contained in the Plan shall constitute a guarantee that the assets of the Company or any Subsidiary shall be sufficient to pay any benefits to any person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The Plan does not constitute a contract of employment or service, and selection as a Grantee will not give any participating Employee, Non-Employee Director or Key Advisor the right to be retained in the employ or service of the Company or any Subsidiary, nor any right or claim to any benefit under the Plan, unless such right or claim has specifically accrued under the terms of the Plan. Except as otherwise provided in the Plan or the Award Agreement, no Award under the Plan shall confer upon the holder thereof any rights as a stockholder of the Company prior to the date on which the individual fulfills all conditions for receipt of such rights.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10 **Section 409A**. It is intended that all Options and SARs granted under the Plan shall be exempt from the provisions of Section 409A of the Code and that all other Awards under the Plan, to the extent that they constitute "non-qualified deferred compensation" within the meaning of Section 409A of the Code, will comply with Section 409A of the Code (and any regulations and guidelines issued thereunder). The Plan and any Award Agreements issued hereunder may be amended in any respect deemed by the Board or the Committee to be necessary in order to preserve compliance with Section 409A of the Code. Notwithstanding anything in this Plan to the contrary, if required by Section 409A of the Code, if a Grantee is considered a "specified employee" for purposes of Section 409A of the Code and if payment of any Award under this Plan is required to be delayed for a period of six months after "separation from service" within the meaning of Section 409A of the Code, payment of such Award shall be delayed as required by Section 409A of the Code, and the accumulated amounts with respect to such Award shall be paid in a lump sum payment within ten days after the end of the six month period. If the Grantee dies during the postponement period prior to the payment of benefits, the amounts withheld on account of Section 409A of the Code shall be paid to the Grantee's beneficiary within sixty (60) days after the date of the Grantee's death. For purposes of Section 409A of the Code, each payment under the Plan shall be treated as a separate payment. In no event shall a Grantee, directly or indirectly, designate the calendar year of payment. To the extent that any provision of the Plan would cause a conflict with the requirements of section 409A of the Code, or would cause the administration of the Plan to fail to satisfy the requirements of Section 409A of the Code, such provision shall be deemed null and void to the extent permitted by applicable law. Notwithstanding anything in the Plan or any Award Agreement to the contrary, each Grantee shall be solely responsible for the tax consequences of Awards under the Plan, and in no event shall the Company have any responsibility or liability if an Award does not meet any applicable requirements of Section 409A of the Code. Although the Company intends to administer the Plan to prevent taxation under Section 409A of the Code, the Company does not represent or warrant that the Plan or any Award complies with any provision of federal, state, local or other tax law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11 **Regulations and Other Approvals**.

&nbsp;&nbsp;&nbsp;&nbsp;(i) The obligation of the Company to sell or deliver Stock with
respect to any Award granted under the Plan shall be subject to all applicable laws, rules and regulations, including all applicable
federal and state securities laws, and the obtaining of all such approvals by governmental agencies as may be deemed necessary or appropriate
by the Committee.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) Each Award is subject to the requirement that, if at any time
the Committee determines, in its absolute discretion, that the listing, registration or qualification of Stock issuable pursuant to the
Plan is required by any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory
body is necessary or desirable as a condition of, or in connection with, the grant of an Award or the issuance of Stock, no such Award
shall be granted or payment made or Stock issued, in whole or in part, unless listing, registration, qualification, consent or approval
has been effected or obtained free of any conditions not acceptable to the Committee.

&nbsp;&nbsp;&nbsp;&nbsp;(iii) In the event that the disposition of Stock acquired pursuant
to the Plan is not covered by a then current registration statement under the Securities Act and is not otherwise exempt from such registration,
such Stock shall be restricted against transfer to the extent required by the Securities Act of 1933, as amended, or regulations
thereunder, and applicable state securities laws, and the Committee may require a Grantee receiving Stock pursuant to the Plan, as a
condition precedent to receipt of such Stock, to represent to the Company in writing that the Stock acquired by such Grantee is acquired
for investment only and not with a view to distribution.

&nbsp;&nbsp;&nbsp;&nbsp;(iv) With respect to persons subject to section 16 of the Exchange Act,
it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3.

&nbsp;&nbsp;&nbsp;&nbsp;(v) All Awards under the Plan will be subject to any compensation,
clawback and recoupment policies that may be applicable to the employees of the Company, as in effect from time to time and as approved
by the Board or Committee, whether or not approved before or after the Effective Date. Subject to the requirements of applicable law,
any such compensation, clawback and recoupment policies shall apply to Awards made after the effective date of the policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.12 **Non-Employee Director Award Deferrals**. The Committee may permit a Non-Employee Director to defer receipt of the payment of cash or the delivery of shares that would otherwise be due to such Non-Employee Director in connection with any Restricted Stock, Restricted Stock Units, Other Stock-Based Awards or Cash-Based Awards. If any such deferral election is permitted, the Committee shall establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals, which rules and procedures shall be consistent with applicable requirements of Section 409A of the Code. Unless otherwise specified in a Non-Employee Director's valid election, any deferred amount will be deferred until the earliest to occur of the Non-Employee Director's death, separation from service, or Change of Control; provided that any such deferral election is made by the Non-Employee Director on or prior to December 31 of the calendar year preceding the calendar year in which any such amounts are earned, or, if such Non-Employee Director is newly eligible for purposes of Section 409A of the Code, then within 30 days following the date he or she is first eligible, and then only with respect to amounts earned after the date of the election.

**6 Amendment and Termination**

The Plan may be terminated or amended by the Board at any time, except that the following actions may not be taken without stockholder approval:

&nbsp;&nbsp;&nbsp;&nbsp;(i) any increase in the number of shares that may be issued under
the Plan (except by certain adjustments provided for under the Plan);

&nbsp;&nbsp;&nbsp;&nbsp;(ii) any change in the class of persons eligible to receive ISOs
under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;(iii) any change in the requirements of Sections 4.2(i)(b) and
4.2(ii)(c) hereof regarding the exercise price of Options and the grant price of SARs;

&nbsp;&nbsp;&nbsp;&nbsp;(iv) any repricing or cancellation and regrant of any Option or,
if applicable, other Award at a lower exercise, base or purchase price, whether in the form of an amendment, cancellation or replacement
grant, or a cash-out of underwater options or any action that provides for Awards that contain a so-called "reload"
feature under which additional Options or other Awards are granted automatically to the Grantee upon exercise of the original Option
or Award; or

&nbsp;&nbsp;&nbsp;&nbsp;(v) any other amendment to the Plan that would require approval
of the Company's stockholders under applicable law, regulation or rule or stock exchange listing requirement.

Notwithstanding any of the foregoing, adjustments pursuant to Section 3 shall not be subject to the foregoing limitations of this Section 6.

**7 Governing Law**

The Plan and all Award Agreements entered into under the Plan shall be construed in accordance with and governed by the laws of the State of New York, except that any principles or provisions of New York law that would apply the law of another jurisdiction (other than applicable provisions of U.S. Federal law) shall be disregarded. Notwithstanding the foregoing, matters with respect to indemnification, delegation of authority under the Plan, and the legality of shares of Stock issued under the Plan, shall be governed by the Nevada Revised Statutes.

**8 Severability**

If any of the provision of this Plan is finally held to be invalid, illegal or unenforceable (whether in whole or in part), such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected thereby; provided that, if any such provision is finally held to be invalid, illegal or unenforceable because it exceeds the maximum scope determined to be acceptable to permit such provision to be enforceable, such provision shall be deemed modified to the minimum extent necessary in order to make such provision enforceable.